[Federal Register Volume 63, Number 80 (Monday, April 27, 1998)]
[Notices]
[Pages 20642-20643]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-11111]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Exclusive License: Spectroscopic Imaging 
Device Employing Imaging Quality Spectral Filters

AGENCY: National Institutes of Health, Public Health Service, DHHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is notice in accordance with 15 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(I) that the National Institutes of Health (NIH), 
Department of Health and Human Services, is contemplating the grant of 
an exclusive license to practice the invention embodied in U.S. Patent 
Number 5,377,003 and U.S. Patent Application Number 08/996,497, 
entitled ``Spectroscopic Imaging Device Employing Imaging Quality 
Spectral Filters'', to Spectral Dimensions, Inc., having a place of 
business in Boston, Massachusetts. The patent rights in this 
application have been assigned to the United States of America.
    The prospective exclusive license will be royalty-bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7 
and may be limited to the field of use of veterinary and human clinical 
diagnosis.

DATES: Only written comments and/or applications for a license which 
are received by the NIH Office of Technology Transfer on or before June 
26, 1998 will be considered.

ADDRESSES: Requests for a copy of this patent application, inquiries, 
comments, and other materials relating to the contemplating license 
should be directed to: John Fahner-Vihtelic, Office of Technology 
Transfer, National Institutes of Health, 6011 Executive Boulevard, 
Suite 325, Rockville, Maryland 20852-3804; Telephone: 301/496-7735 ext. 
270; Fax: 301/402-0220; e-mail: <a href="/cdn-cgi/l/email-protection#0f65693c39754f61666721686079"><span class="__cf_email__" data-cfemail="2b414d181d516b454243054c445d">[email protected]</span></a>. A signed Confidentiality 
Agreement will be required to review copies of the patent application.


[[Page 20643]]


SUPPLEMENTARY INFORMATION: The present technology is a novel imaging 
device and methodology which integrates both light microscopy and 
spectroscopy. This invention allows for the cost-effective development 
of high-resolution spatial, chemical, and spectral images. It provides 
a rapid means for examining and collecting large format images from 
vibrational and visible spectra in a three-dimensional sample. It is 
superior to current equipment because it has no moving parts. This 
device may be used as a tool for the characterization of polymers, 
semiconductors, contamination studies, analysis of diffusion and 
failure mechanisms, and has potential as a diagnostic tool of clinical 
analysis of histologic materials.
    The prospective exclusive license may be granted unless, within 60 
days from the date of this published Notice, NIH receives written 
evidence and argument that establishes that the grant of the license 
would not be consistent with the requirements of 35 U.S.C. 209 and 37 
CFR 404.7. Properly filed competing applications for a license filed in 
response to this notice will be treated as objections to the 
contemplated license.
    Comments and objections submitted in response to this notice will 
not be made available for public inspection, and, to the extent 
permitted by law, will not be released under the Freedom of Information 
Act, 5 U.S.C. 552.

    Dated: April 17, 1998.
Jack Spiegel,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer.
[FR Doc. 98-11111 Filed 4-24-98; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>